Advanced Enzyme Technologies Limited

NSEI:ADVENZYMES Rapport sur les actions

Capitalisation boursière : ₹50.7b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Advanced Enzyme Technologies Croissance future

Future contrôle des critères 4/6

Advanced Enzyme Technologies devrait augmenter ses bénéfices et ses revenus de 23.2% et de 12.7% par an respectivement, tandis que le BPA devrait croître de croître de 23.3% par an.

Informations clés

23.2%

Taux de croissance des bénéfices

23.3%

Taux de croissance du BPA

Chemicals croissance des bénéfices20.4%
Taux de croissance des recettes12.7%
Rendement futur des capitaux propresn/a
Couverture par les analystes

Low

Dernière mise à jour17 May 2024

Mises à jour récentes de la croissance future

Recent updates

After Leaping 26% Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Shares Are Not Flying Under The Radar

Aug 20
After Leaping 26% Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Shares Are Not Flying Under The Radar

We Think Shareholders Are Less Likely To Approve A Pay Rise For Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) CEO For Now

Jul 19
We Think Shareholders Are Less Likely To Approve A Pay Rise For Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) CEO For Now

Advanced Enzyme Technologies (NSE:ADVENZYMES) Has Affirmed Its Dividend Of ₹1.00

Jul 13
Advanced Enzyme Technologies (NSE:ADVENZYMES) Has Affirmed Its Dividend Of ₹1.00

Advanced Enzyme Technologies' (NSE:ADVENZYMES) Returns On Capital Not Reflecting Well On The Business

Apr 08
Advanced Enzyme Technologies' (NSE:ADVENZYMES) Returns On Capital Not Reflecting Well On The Business

Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends

Sep 23
Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends

Advanced Enzyme Technologies (NSE:ADVENZYMES) Could Be Struggling To Allocate Capital

Feb 03
Advanced Enzyme Technologies (NSE:ADVENZYMES) Could Be Struggling To Allocate Capital

Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends

Aug 11
Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends

With EPS Growth And More, Advanced Enzyme Technologies (NSE:ADVENZYMES) Is Interesting

May 13
With EPS Growth And More, Advanced Enzyme Technologies (NSE:ADVENZYMES) Is Interesting

Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Paint A Concerning Picture

Mar 28
Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Paint A Concerning Picture

The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 185%, So Why Not Pay It Some Attention?

Mar 13
The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 185%, So Why Not Pay It Some Attention?

Don't Ignore The Fact That This Insider Just Sold Some Shares In Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)

Feb 21
Don't Ignore The Fact That This Insider Just Sold Some Shares In Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)

Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Feb 18
Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

I Built A List Of Growing Companies And Advanced Enzyme Technologies (NSE:ADVENZYMES) Made The Cut

Feb 03
I Built A List Of Growing Companies And Advanced Enzyme Technologies (NSE:ADVENZYMES) Made The Cut

What Kind Of Investors Own Most Of Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)?

Jan 19
What Kind Of Investors Own Most Of Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)?

What Do The Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Tell Us?

Dec 28
What Do The Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Tell Us?

The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 114%, So Why Not Pay It Some Attention?

Dec 13
The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 114%, So Why Not Pay It Some Attention?

Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?

Nov 28
Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?

Are Strong Financial Prospects The Force That Is Driving The Momentum In Advanced Enzyme Technologies Limited's NSE:ADVENZYMES) Stock?

Nov 20
Are Strong Financial Prospects The Force That Is Driving The Momentum In Advanced Enzyme Technologies Limited's NSE:ADVENZYMES) Stock?

Here's Why I Think Advanced Enzyme Technologies (NSE:ADVENZYMES) Might Deserve Your Attention Today

Nov 05
Here's Why I Think Advanced Enzyme Technologies (NSE:ADVENZYMES) Might Deserve Your Attention Today

What You Need To Know About Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Investor Composition

Oct 21
What You Need To Know About Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Investor Composition

Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?

Oct 06
Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?

Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Stocks Shoot Up 31% But Its P/E Still Looks Reasonable

Sep 26
Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Stocks Shoot Up 31% But Its P/E Still Looks Reasonable

Our Take On The Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES)

Sep 21
Our Take On The Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES)

Prévisions de croissance des bénéfices et des revenus

NSEI:ADVENZYMES - Estimations futures des analystes et données financières antérieures (INR Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
3/31/20267,8882,1142,105N/A1
3/31/20257,0141,7972,892N/A1
6/30/20246,3111,386N/AN/AN/A
3/31/20246,2391,3339411,414N/A
12/31/20236,0481,371N/AN/AN/A
9/30/20235,8591,2489651,327N/A
6/30/20235,6681,166N/AN/AN/A
3/31/20235,4061,0561,0221,404N/A
12/31/20225,337979N/AN/AN/A
9/30/20225,2519608061,164N/A
6/30/20225,135995N/AN/AN/A
3/31/20225,2941,1969411,223N/A
12/31/20215,3091,268N/AN/AN/A
9/30/20215,3501,4241,1271,374N/A
6/30/20215,3251,500N/AN/AN/A
3/31/20215,0181,4591,4341,630N/A
12/31/20204,8201,459N/AN/AN/A
9/30/20204,5691,3649781,472N/A
6/30/20204,4811,301N/AN/AN/A
3/31/20204,4401,2939041,409N/A
12/31/20194,4801,302N/AN/AN/A
9/30/20194,3661,2101,1471,276N/A
6/30/20194,2881,148N/AN/AN/A
3/31/20194,2201,1111,1621,286N/A
12/31/20184,1941,061N/AN/AN/A
9/30/20184,2611,068N/AN/AN/A
6/30/20184,1991,039N/AN/AN/A
3/31/20183,918901N/A1,160N/A
12/31/20173,660837N/AN/AN/A
9/30/20173,213725N/AN/AN/A
6/30/20173,127793N/AN/AN/A
3/31/20173,290915N/A1,074N/A
12/31/20163,260942N/AN/AN/A
9/30/20163,404998N/AN/AN/A
6/30/20163,184854N/AN/AN/A
3/31/20162,938759N/A934N/A
3/31/20152,233510N/A537N/A
3/31/20142,397201N/A433N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de ADVENZYMES ( 23.2% par an) est supérieure au taux d'épargne ( 6.7% ).

Bénéfices vs marché: Les bénéfices de ADVENZYMES ( 23.2% par an) devraient croître plus rapidement que le marché Indian ( 16.9% par an).

Croissance élevée des bénéfices: Les bénéfices de ADVENZYMES devraient augmenter de manière significative au cours des 3 prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de ADVENZYMES ( 12.7% par an) devrait croître plus rapidement que le marché Indian ( 10% par an).

Croissance élevée des revenus: Le chiffre d'affaires de ADVENZYMES ( 12.7% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Données insuffisantes pour déterminer si le retour sur capitaux propres de ADVENZYMES devrait être élevé dans 3 ans

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y